Skip to content

Clinical trials

Neuromyelitis Optica trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromyelitis Optica Country / region: United States Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20061
20081
20093
20123
20132
20146
20152
20162
20182
20195
20201
20215
20223
20234
20244
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting14
Active, not recruiting5
Terminated4
Withdrawn4
Enrolling by invitation2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.7
Hoffmann-La Roche5
Johns Hopkins University4
Amgen3
Icahn School of Medicine at Mount Sinai3
Mayo Clinic3
University of Texas Southwestern Medical Center3
Jagannadha R Avasarala2
MD Stem Cells2
Northwestern University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromyelitis Optica52
Myelitis, Transverse11
Optic Neuritis10
Multiple Sclerosis9
Demyelinating Diseases6
Recurrence4
Autoimmune Diseases of the Nervous System3
Multiple Sclerosis, Relapsing-Remitting3
Myasthenia Gravis3
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating3

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.